News

News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.

Featured news

UK medicines regulator, MHRA approves lecanemab

The UK medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the marketing authorisation for lecanemab in the treatment of early Alzheimer’s disease. However, the treatment will not be available through the National Health Service (NHS), the UK’s publicly funded health agency.

Published date:

Dementia in the Caribbean: No time to lose

The 4th Regional non-Latin Caribbean Conference on Alzheimer’s and Dementia was hosted by the Alzheimer's Association of Trinidad and Tobago and ADI in Port of Spain.

Published date:
Paola Barbarino

Paola Barbarino appointed as new CEO

ADI is excited to announce that Paola Barbarino has been appointed as our new CEO. Paola will assume the role on 15 May 2017, after which there will be a period of transition alongside outgoing Executive Director, Marc Wortmann. Marc will be leaving his position after more than ten years…

Published date: